Vanda Pharmaceuticals Inc (VNDA)
4.485
-0.08
(-1.64%)
USD |
NASDAQ |
Apr 25, 16:00
4.49
0.00 (0.00%)
After-Hours: 17:01
Vanda Pharmaceuticals Price: 4.485 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 4.63 | 4.67 | 4.551 | 4.56 | 1.184M |
| Apr 23, 2024 | 4.76 | 4.87 | 4.62 | 4.63 | 1.371M |
| Apr 22, 2024 | 5.10 | 5.12 | 4.785 | 4.80 | 2.115M |
| Apr 19, 2024 | 4.94 | 5.30 | 4.93 | 5.11 | 2.441M |
| Apr 18, 2024 | 5.16 | 5.245 | 4.89 | 4.97 | 3.860M |
| Apr 17, 2024 | 5.42 | 5.67 | 4.99 | 5.24 | 24.04M |
| Apr 16, 2024 | 4.02 | 4.08 | 3.985 | 4.05 | 790418.0 |
| Apr 15, 2024 | 4.12 | 4.16 | 4.01 | 4.06 | 787157.0 |
| Apr 12, 2024 | 4.27 | 4.30 | 4.08 | 4.12 | 762864.0 |
| Apr 11, 2024 | 4.30 | 4.32 | 4.18 | 4.28 | 766830.0 |
| Apr 10, 2024 | 4.30 | 4.37 | 4.14 | 4.28 | 1.159M |
| Apr 09, 2024 | 4.49 | 4.68 | 4.34 | 4.36 | 1.795M |
| Apr 08, 2024 | 4.83 | 4.83 | 4.49 | 4.51 | 1.690M |
| Apr 05, 2024 | 4.97 | 4.99 | 4.79 | 4.82 | 1.670M |
| Apr 04, 2024 | 5.14 | 5.44 | 4.84 | 4.92 | 6.158M |
| Apr 03, 2024 | 4.65 | 6.03 | 4.37 | 5.05 | 50.71M |
| Apr 02, 2024 | 4.02 | 4.020 | 3.87 | 3.91 | 2.123M |
| Apr 01, 2024 | 4.23 | 4.24 | 4.085 | 4.12 | 735827.0 |
| Mar 28, 2024 | 3.92 | 4.19 | 3.91 | 4.11 | 1.372M |
| Mar 27, 2024 | 3.89 | 3.92 | 3.86 | 3.89 | 799666.0 |
| Mar 26, 2024 | 3.92 | 3.98 | 3.86 | 3.86 | 604360.0 |
| Mar 25, 2024 | 3.88 | 3.98 | 3.855 | 3.87 | 593607.0 |
| Mar 22, 2024 | 3.98 | 3.98 | 3.85 | 3.89 | 514541.0 |
| Mar 21, 2024 | 3.85 | 3.97 | 3.79 | 3.91 | 883248.0 |
| Mar 20, 2024 | 3.77 | 3.85 | 3.71 | 3.80 | 613734.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.38
Minimum
Nov 09 2023
21.51
Maximum
Jun 30 2021
11.40
Average
11.32
Median
Feb 26 2020
Price Benchmarks
| ADMA Biologics Inc | 6.445 |
| INVO Bioscience Inc | 0.965 |
| Johnson & Johnson | 146.84 |
| Nektar Therapeutics | 1.32 |
| Invivyd Inc | 2.06 |
Price Related Metrics
| PE Ratio | 85.63 |
| PS Ratio | 1.340 |
| Price to Book Value | 0.4736 |
| Price to Free Cash Flow | 20.79 |
| Earnings Yield | 1.17% |
| Market Cap | 258.06M |
| Normalized PE Ratio | 85.63 |